L. Lukacs

Safety and immunogenicity of Haemophilus influenzae type B-Neisseria meningitidis group B outer membrane protein complex conjugate vaccine mixed in the syringe with diphtheria-tetanus-pertussis vaccine in young Gambian infants.

E. Mulholland, B. Greenwood, J. Todd, 1993, The Pediatric infectious disease journal.

Anti-PRP antibody levels after a primary series of PRP-OMPC and persistence of antibody titres following primary and booster doses.

J. Ryan, D. Greenberg, G. Calandra, 1993, Vaccine.

Haemophilus influenzae type b conjugate vaccine (meningococcal protein conjugate) (PedvaxHIB): clinical evaluation.

K. Dolan, G. Calandra, H. Matthews, 1990, Pediatrics.

Safety and immunogenicity of a Haemophilus influenzae type b conjugate vaccine in a high risk American Indian population

M. Santosham, R. Reid, M. Wolff, 1991, The Pediatric infectious disease journal.

Clinical experience with PedvaxHIB, a conjugate vaccine of Haemophilus influenzae type b polysaccharide--Neisseria meningitidis outer membrane protein.

G. Calandra, L. Jonas, V. Ahonkhai, 1991, Vaccine.

CHANGES IN ANTIBIOTIC RESISTANCE INDICES OF ANIMAL ESCHERICHIA COLI STRAINS WITH NUMBER OF ISOLATES

M. Niculae, M. Spînu, D. Cadar, 2012 .

The efficacy in Navajo infants of a conjugate vaccine consisting of Haemophilus influenzae type b polysaccharide and Neisseria meningitidis outer-membrane protein complex.

D. Sack, S. Gahagan, G. Calandra, 1991, The New England journal of medicine.

Haemophilus influenzae type b conjugate vaccine (meningococcal protein conjugate) (PedvaxHIB): clinical evaluation.

G. Calandra, H. Matthews, R. Ellis, 1990, Pediatrics.